Demo Data from VLDB 2026 / reviewers in the wild / expert
Sudeep Sarma
dblp:429/6712
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2026
0000-0002-4642-7689ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Artificial intelligence and machine learning · 1 · 1 since 2021Graphics, computer vision, multimedia, augmented reality and games · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 50% Medical and health informatics · 50% | |
| Artificial intelligence
1 paper |
Learning paradigms · 100% |
Topics — the 2 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
protein-protein interaction prediction |
1.0 | 1 | 2026 | Machine Learning Models Assisting the Development of Antibody Therapeutics and Vaccines - an Emerging Trend · AAAI 2026 |
Machine learning › Learning paradigms › supervised learning
property prediction |
0.3 | 1 | 2026 | Machine Learning Models Assisting the Development of Antibody Therapeutics and Vaccines - an Emerging Trend · AAAI 2026 |
Methods — techniques the papers use, named apart from their topics
machine learning property prediction · 2.0
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2026 | Machine Learning Models Assisting the Development of Antibody Therapeutics and Vaccines - an Emerging TrendabstractThe development of novel effective medical treatments is one of the most important and expected beneficial effects of the AI revolution. This decade is witnessing the rise of AI models able to predict complex properties for protein-protein interactions that hold great promise in assisting in the development of antibody therapeutics and vaccines, including for diseases that long eluded us in the pursuit of an effective treatment. This paper introduces this area of research in a language accessible to an AI researcher, exploring the biological problems that can be solved by AI models, as well as the general context to make solutions feasible in practical scenarios. We survey the main current trends and works in this research area and point towards current still unsolved challenges and trade offs. We expect this paper will be extremely helpful for AI researchers trying to join the field, as well as for researchers already working in one of the subtopics that wish to have a better understanding of the general context around it. Felipe Leno da Silva, Mikel Landajuela, Edwin A. Saada, Piyush Karande, Sudeep Sarma, Igor D'Angelo, Simone Conti, Daniel M. Faissol |
AAAI | 5 |